I came to London to report about higher education but I stayed for the austerity.

Merck KGaA Earnings Miss Estimates on Higher Research Costs

bloomberg.com — Merck KGaA's profit rose 5.7 percent in the first quarter as the German drug and specialty materials maker benefited from sales of fertility drugs and liquid crystals. Earnings before interest, taxes, depreciation and amortization excluding one-time items climbed to 853 million euros ($964.3 million) from 807.1 million euros a year earlier, the Darmstadt, Germany-based company said in a statement.

AstraZeneca-Novartis Three-Drug Melanoma Treatment Found Safe

bloomberg.com — A first-of-its-kind combination of three drugs to treat a deadly form of skin cancer can be taken safely, passing the first hurdle to regulatory approval for a potentially long-lasting treatment. The treatment was tested in an early-stage trial that was a collaboration between AstraZeneca Plc and Novartis AG.

Glaxo Cuts Payment to Investors as Earnings Miss Estimates

bloomberg.com — GlaxoSmithKline Plc, the U.K.'s biggest drug company, reported first-quarter earnings that missed analyst estimates and said it would reduce a special dividend to 1 billion pounds ($1.52 billion) from 4 billion pounds. Profit excluding certain items slipped to 17.3 pence a share, from 21 pence a year earlier, the London-based company said in a statement.

Prescription for Glaxo: A New Boss?

bloomberg.com — Philip Hampton is taking over as chairman of GlaxoSmithKline Plc as Chief Executive Officer Andrew Witty struggles to win back investors' favor. Witty, who's led Britain's largest drugmaker since 2008, is facing criticism for Glaxo's lagging share performance and a depleted pipeline of promising medicines.

Chimps Give Way to Chips as Drug Makers Seek Lower Costs

bloomberg.com — To test a potential cure for hepatitis B, Benitec Biopharma Ltd. could have infected as many as 50 chimpanzees with the liver disease, then given them the drug and watched what happened. Instead, the Australian company turned to a U.K. startup for "livers on a chip" contaminated with the virus.

AstraZeneca’s profit dips

iol.co.za — London - AstraZeneca, the second-largest UK drugmaker, said earnings fell in the first quarter as sales of two of its biggest medicines continued to decline and currency fluctuations took a slice from revenue. Profit excluding certain items slipped to $1.37 billion, or $1.08 a share, from $1.47 billion, or $1.17 a share, a year ago, the company said in a statement.

AstraZeneca Profit Falls as Top Drugs Lose Patent Protection

bloomberg.com — AstraZeneca Plc, the second-largest U.K. drugmaker, said earnings fell in the first quarter as sales of two of its biggest medicines continued to decline and currency fluctuations took a slice from revenue. Profit excluding certain items slipped to $1.37 billion, or $1.08 a share, from $1.47 billion, or $1.17 a share, a year ago, the company said in a statement.

Mylan $23 Million Chairman Shows Looming Teva Culture Clash

bloomberg.com — Mylan NV Executive Chairman Robert Coury made $22.7 million, including $1 million for his personal use of the drugmaker's two corporate jets, in 2012 and 2013. At Israeli rival Teva, shareholders in 2012 balked at raising the chairman's salary to $900,000 a year.

Faster FDA Spurs Cancer Breakthroughs

bloomberg.com — (Bloomberg) -- More new drugs are getting the green light in the U.S. as drugmakers take advantage of a speedier metabolism at the Food and Drug Administration. Through March 19, the FDA has approved 10 new drugs, on pace to match last year's total of 41, which was an 18-year high.

Last Mile of Ebola Eradication Is Seen as the Most Difficult

bloomberg.com — (Bloomberg) -- One year after Ebola was declared an epidemic in West Africa, significant progress has been made to eradicate the disease. The last steps are more difficult, according to the United Nations special envoy for the outbreak.
More Articles →
May 22, 2015

@tsrandall What is the governing authority in space that arbitrates mineral rights disputes? The Shi'ar Empire?

May 22, 2015

RT @tsrandall: The House just passed a bill about space mining. If you catch an asteroid, it's yours wpo.st/s1VI0 pic.twitter.com/EVa6E6r1i3

May 22, 2015

@bizboyle @business so long it costs 99 cents, they can call it what ever they want

May 22, 2015

The UK *slightly* underestimates how much it drinks. By about 12 million bottles a year. Via @SimeonBennett bloomberg.com/news/articles/…

May 21, 2015

Based on my hotel reviews, @TripAdvisor is trying to entice me with a vacation to Oklahoma City. Keep trying, algorithm, keep trying.

May 21, 2015

The World's Most Expensive Medicine: Is the drug for a rare genetic disorder worth $1 million? via @maki_kitamura bloomberg.com/news/articles/…



Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.

Email

For instructions on how to pitch Oliver Staley, email ostaley@muckrack.com.


Share This Profile